Search research articles
Contact Us
Filters
Showing results (21-30 of 79) with videos related to
Page
of 8
Sort By:
British Journal of Haematology
|
October 31, 2002
AC133+ umbilical cord blood progenitors demonstrate rapid self-renewal and low apoptosis
Nicolas Forraz, Ruth Pettengell, Pierre-Antoine Deglesne, et al.
Clinical Immunology (Orlando, Fla.)
|
November 19, 2016
Enhanced formation of giant cells in common variable immunodeficiency: Relation to granulomatous disease
Timothy H Scott-Taylor, Karen Whiting, Ruth Pettengell, et al.
Immunity, Inflammation and Disease
|
November 23, 2017
Immunoglobulin G; structure and functional implications of different subclass modifications in initiation and resolution of allergy
Timothy H Scott-Taylor, Stefan-Claudiu Axinia, Sumeya Amin, et al.
BMC Cancer
|
August 24, 2012
Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin's lymphoma in European and Australian clinical practice
Derek Weycker, Aurelie Danel, Anne Marciniak, et al.
Leukemia Research
|
August 23, 2005
HOXA9 expression increases with age in human haemopoietic cells
Richard Morgan, Ruji Begum, Davinder Theti, et al.
Leukemia & Lymphoma
|
March 5, 2013
External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma
Matthias Schwenkglenks, Kate Louise Bendall, Alena M Pfeil, et al.
Journal of Hematology & Oncology
|
August 21, 2010
Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery
Matthias Schwenkglenks, Ruth Pettengell, Thomas D Szucs, et al.
British Journal of Haematology
|
August 22, 2003
Three-dimensional analysis of CD34 sialomucin distribution on cord blood and bone marrow
Karen A Whiting, Colin P McGuckin, David Wertheim, et al.
Leukemia & Lymphoma
|
February 1, 2019
Treatment of aggressive B-cell non-Hodgkin lymphoma beyond frontline therapy in patients not eligible for stem cell transplantation: a structured review
Gilles A Salles, Ruth Pettengell, Raul Cordoba, et al.
Cancer Research
|
June 19, 2007
Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma
Richard Morgan, Patricia Macanas Pirard, Liesl Shears, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 79) with videos related to
Sort By:
Page
of 8
British Journal of Haematology
|
October 31, 2002
AC133+ umbilical cord blood progenitors demonstrate rapid self-renewal and low apoptosis
Nicolas Forraz, Ruth Pettengell, Pierre-Antoine Deglesne, et al.
Clinical Immunology (Orlando, Fla.)
|
November 19, 2016
Enhanced formation of giant cells in common variable immunodeficiency: Relation to granulomatous disease
Timothy H Scott-Taylor, Karen Whiting, Ruth Pettengell, et al.
Immunity, Inflammation and Disease
|
November 23, 2017
Immunoglobulin G; structure and functional implications of different subclass modifications in initiation and resolution of allergy
Timothy H Scott-Taylor, Stefan-Claudiu Axinia, Sumeya Amin, et al.
BMC Cancer
|
August 24, 2012
Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin's lymphoma in European and Australian clinical practice
Derek Weycker, Aurelie Danel, Anne Marciniak, et al.
Leukemia Research
|
August 23, 2005
HOXA9 expression increases with age in human haemopoietic cells
Richard Morgan, Ruji Begum, Davinder Theti, et al.
Leukemia & Lymphoma
|
March 5, 2013
External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma
Matthias Schwenkglenks, Kate Louise Bendall, Alena M Pfeil, et al.
Journal of Hematology & Oncology
|
August 21, 2010
Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery
Matthias Schwenkglenks, Ruth Pettengell, Thomas D Szucs, et al.
British Journal of Haematology
|
August 22, 2003
Three-dimensional analysis of CD34 sialomucin distribution on cord blood and bone marrow
Karen A Whiting, Colin P McGuckin, David Wertheim, et al.
Leukemia & Lymphoma
|
February 1, 2019
Treatment of aggressive B-cell non-Hodgkin lymphoma beyond frontline therapy in patients not eligible for stem cell transplantation: a structured review
Gilles A Salles, Ruth Pettengell, Raul Cordoba, et al.
Cancer Research
|
June 19, 2007
Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma
Richard Morgan, Patricia Macanas Pirard, Liesl Shears, et al.
Page
of 8